TG and Hand-foot syndrome: The above clinical studies found that hypertension, elevated thyroid-stimulating hormone, hand-and-foot syndrome, elevated thyroglobulin, elevated total cholesterol, and diarrhea[2, 3] were frequently observed during treatment with anlotinib.